DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,255,026 | -30.2% | 109,855 | -32.5% | 0.26% | -26.2% |
Q2 2023 | $39,042,587 | +8.0% | 162,650 | -55.6% | 0.36% | +2.9% |
Q2 2018 | $36,154,000 | -5.5% | 366,379 | -6.2% | 0.35% | -12.3% |
Q1 2018 | $38,255,000 | -12.3% | 390,713 | -16.8% | 0.40% | -6.8% |
Q4 2017 | $43,604,000 | -17.0% | 469,766 | -23.3% | 0.43% | -25.7% |
Q3 2017 | $52,524,000 | -29.6% | 612,313 | -29.8% | 0.58% | -32.5% |
Q2 2017 | $74,585,000 | 0.0% | 872,037 | 0.0% | 0.85% | 0.0% |
Q1 2017 | $74,585,000 | +6.4% | 872,037 | -3.2% | 0.85% | +4.4% |
Q4 2016 | $70,110,000 | +4.4% | 900,700 | +5.2% | 0.82% | -3.1% |
Q3 2016 | $67,133,000 | -21.9% | 856,400 | +0.6% | 0.84% | -23.9% |
Q2 2016 | $86,002,000 | +4.1% | 851,500 | -2.2% | 1.11% | +2.0% |
Q1 2016 | $82,598,000 | +14.6% | 870,738 | +12.2% | 1.08% | +7.1% |
Q4 2015 | $72,051,000 | +27.0% | 775,745 | +16.5% | 1.01% | +17.7% |
Q3 2015 | $56,754,000 | -17.3% | 666,045 | -17.0% | 0.86% | -9.7% |
Q2 2015 | $68,654,000 | -15.6% | 802,123 | -16.3% | 0.95% | -6.8% |
Q1 2015 | $81,357,000 | -1.6% | 958,263 | -0.7% | 1.02% | -2.1% |
Q4 2014 | $82,710,000 | – | 965,001 | – | 1.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |